Samantha McLemore
Net sellingPatient Capital Management, LLC — managed by Samantha McLemore; US equity positions disclosed quarterly via SEC 13F
Data as of 2026-06-30 (filed 2026-08-13) · Source: SEC EDGAR
New
Added
Exited
By what price implies: 6 demand a demanding growth rate, 9 modest.
13F × valuation
Valuation posture
Of 9 valued US positions, 2 trade below a conservative value band (as of 2026-08-25):
- Adobe IncADBE21% · below
- Fiserv IncFISV20% · below
13F · concentration
Lonely conviction
2Held by ≤2 tracked superinvestors, each ≥3% of this portfolio (as of 2026-06-30):
- Qxo IncQXO4% · 2
- Precigen IncPGEN4% · 1
SEC 13F · latest filing
Holdings
- Royalty Pharma PlcRPRXCore 8qValue$201.8MValuation—Holders3Weight6.7%
- Citigroup IncCCore 8qValue$196.4MValuation—Holders13Weight6.5%
- Alphabet IncGOOGLCore 8qValue$187.9MValuation—Holders41Weight6.2%
- Unitedhealth Group IncUNHBig newValue$182.0MValuation—Holders19Weight6.0%
- Amazon Com IncAMZNAdding 3qValue$162.3MValuation—Holders39Weight5.4%
- Value$142.0MValuation—Holders18Weight4.7%
- Value$127.8MValuation—Holders14Weight4.2%
- Norwegian Cruise Line HldgsNCLHAdding 3qValue$127.3MValuation—Holders3Weight4.2%
- Qxo IncQXOBig newValue$123.3MValuation—Holders2Weight4.1%
- Value$116.3MValuation—Holders5Weight3.9%
- Value$112.0MValuation—Holders3Weight3.7%
- Precigen IncPGENBig newValue$108.5MValuation—Holders1Weight3.6%
- Value$99.5MValuation—Holders5Weight3.3%
- Value$96.4MValuation—Holders9Weight3.2%
- Value$96.2MValuation—Holders35Weight3.2%
- Chime Finl IncCHYMAdding 3qValue$83.6MValuation—Holders3Weight2.8%
- Value$74.0MValuationBelow valueHolders13Weight2.5%
- Value$73.9MValuation—Holders1Weight2.5%
- Value$68.4MValuation—Holders6Weight2.3%
- Coinbase Global IncCOINAdding 3qValue$67.5MValuation—Holders1Weight2.2%
- Value$62.2MValuation—Holders1Weight2.1%
- Value$61.3MValuation—Holders3Weight2.0%
- Value$60.7MValuation—Holders3Weight2.0%
- Value$48.7MValuation—Holders10Weight1.6%
- Value$47.3MValuation—Holders5Weight1.6%
Showing top 25 of 40 positions
About this investor
About this investor
Portfolio overview
Patient Capital Management, LLC's most recent 13F filing, for the quarter ended 2026-06-30, reports 39 positions worth $3.01B. The top 5 holdings represent 31% of that value, a broadly diversified portfolio.
The single largest position is Royalty Pharma Plc at 6.7% of the portfolio, followed by Citigroup Inc at 6.5% and Alphabet Inc at 6.2%.
Against the prior quarter, Samantha McLemore opened 2 new positions, exited 1, added to 11, and trimmed 24. The largest new buy was Global Pmts Inc. The most notable sale was the full exit from Ishares Bitcoin Trust Etf.
Across all 8 quarters on file, Royalty Pharma Plc has appeared in every filing, as has Citigroup Inc. Royalty Pharma Plc currently ranks first by value.
A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.
Samantha McLemore has no positions in the strike zone right now. Browse the whole market by value band
Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-13
Stay Updated
New-quarter 13F moves and valuation updates, to your inbox.